https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=29132930&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 291329302018103120181031
1556-38711532018MarHeart rhythmHeart RhythmA novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.369375369-37510.1016/j.hrthm.2017.10.026S1547-5271(17)31240-7Cardiac resynchronization therapy (CRT) requires a high percentage of ventricular pacing (%Vp) to maximize its clinical benefits. Atrial fibrillation (AF) has been shown to reduce %Vp in CRT due to competition with irregular intrinsic atrioventricular (AV) conduction. We report the results of a prospective randomized crossover trial evaluating the amount of effective CRT delivered during AF with a novel algorithm (eCRTAF).The purpose of this study was to determine whether eCRTAF increases the amount of effective CRT delivered during AF compared to a currently available rate regularization algorithm.Patients previously implanted with a cardiac resynchronization therapy-defibrillator and with a history of AF and intact AV conduction received up to 4 weeks of control (Conducted AF Response) and up to 4 weeks of eCRTAF in a randomized sequence. The percent effective CRT (%eCRT) pacing, which excludes beats without left ventricular capture, %Vp, and mean heart rate (HR) were recorded during AF and sinus rhythm.The eCRTAF algorithm resulted in a significantly higher %eCRT during AF than control (87.8% ± 7.8% vs 80.8% ± 14.3%; P <.001) and %Vp during AF than control (90.0% ± 5.9% vs 83.2% ± 11.9%; P <.001), with a small but statistically significant increase in mean HR of 2.5 bpm (79.5 ± 9.7 bpm vs 77.0 ± 9.9 bpm; P <.001).In a cohort of CRT patients with a history of AF, eCRTAF significantly increased %eCRT pacing and %Vp during AF with a small increase in mean HR. This algorithm may represent a novel noninvasive method of significantly increasing effective CRT delivery during AF, potentially improving CRT response.Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.PlummerChristopher JCJFreeman Hospital, Newcastle upon Tyne, United Kingdom. Electronic address: Chris.Plummer@nuth.nhs.uk.FrankChristopher MCMMount Carmel Clinical Cardiovascular Specialists, Westerville, Ohio.BáriZsoltZClinical Electrophysiology, Department of Cardiology, Medical Centre, Hungarian Defense Forces, Budapest, Hungary.Al HebaishiYahya SYSAdult Cardiology Department, Prince Sultan Cardiac Centre (PSCC), Prince Sultan Military Medical City, Riyadh, Saudi Arabia.KlepferRuth NicholsonRNMedtronic, plc, Mounds View, Minnesota.StadlerRobert WRWMedtronic, plc, Mounds View, Minnesota.GhoshSubhamSMedtronic, plc, Mounds View, Minnesota.LiuShufengSMedtronic, plc, Mounds View, Minnesota.MittalSuneetSValley Health System, Ridgewood, New Jersey.engClinicalTrials.govNCT02222818Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov't20171111
United StatesHeart Rhythm1012003171547-5271IMAlgorithmsAtrial FibrillationphysiopathologytherapyCardiac Resynchronization TherapymethodsCross-Over StudiesHeart Conduction SystemphysiopathologyHeart VentriclesphysiopathologyHumansProspective StudiesTreatment OutcomeAtrial fibrillationBiventricular pacingCardiac resynchronization therapyEffective pacingHeart failure
20175320171115602018111602017111560ppublish2913293010.1016/j.hrthm.2017.10.026S1547-5271(17)31240-7